Fundraising FoxUVLrx Therapeutics
Santa Barbara, US · Founded 2011 · Delaware corporation
Find your way into UVLrx Therapeutics
Sign up to see every warm intro you have to UVLrx Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the UVLrx Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RS
R. Scott GrizzleExecutive
VS
Victor ScheerenExecutiveVictor Scheeren is an executive officer and director at UVLrx Therapeutics, a medical device company developing LED-based therapeutic energy delivery systems for bacterial, viral, and wellness applications.
RM
Ryan MaloneyExecutive
RH
Rowland HansonExecutive
MH
Michael HarterExecutive
VS
Victor SheerenExecutive
SG
Scott GrizzleExecutive
MW
Mitchell WortzmanExecutive
TD
Tom DiGiovanniExecutive
Reported raises · per SEC filings
Form D private placements$1M disclosed across 6 rounds · 2014–2018
▶$40KraisedJun 2018 · 1 investors · Other Health CareRule 506(b)
▶$40KraisedJun 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- SCOTT GRIZZLEDirector
- VICTOR SCHEERENExecutive Officer, Director
- MICHAEL HARTERExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $40K
- Minimum investment
- $30K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$206KraisedNov 2016 · 2 investors · Other Health CareRule 506(b)
▶$206KraisedNov 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael HarterExecutive Officer, Director
- VICTOR SCHEERENExecutive Officer, Director
- Scott GrizzleExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $206K
- Minimum investment
- $10K
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25.2KraisedJul 2015 · 1 investors · Other Health CareRule 506(b)
▶$25.2KraisedJul 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Victor SheerenExecutive Officer, Director
- Michael HarterExecutive Officer, Director
- R. Scott GrizzleExecutive Officer, Director
- Rowland HansonExecutive Officer
- Ryan MaloneyExecutive Officer
- Offering amount
- $2.8M
- Amount sold
- $25.2K
- Minimum investment
- $25.2K
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$385KraisedFeb 2015 · 6 investors · Other Health CareRule 506(b)
▶$385KraisedFeb 2015 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- R. Scott GrizzleExecutive Officer, Director
- Victor ScheerenExecutive Officer, Director
- Ryan MaloneyExecutive Officer
- Rowland HansonExecutive Officer
- Michael HarterExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $385K
- Minimum investment
- $10K
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$144KraisedSep 2014 · 1 investors · BiotechnologyRule 506(b)
▶$144KraisedSep 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Victor ScheerenExecutive Officer, Director
- R. Scott GrizzleExecutive Officer, Director
- Michael HarterExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $144K
- Minimum investment
- $100K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$245KraisedFeb 2014 · 6 investors · BiotechnologyRule 506(b)
▶$245KraisedFeb 2014 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Victor SheerenExecutive Officer, Director
- Michael HarterExecutive Officer, Director
- Scott GrizzleExecutive Officer
- Mitchell WortzmanExecutive Officer
- Tom DiGiovanniExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $245K
- Minimum investment
- $25K
- First sale
- Jan 2014
- Incorporated
- Corporation, Florida, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has UVLrx Therapeutics raised?
- UVLrx Therapeutics has disclosed $1M raised across 6 rounds.
- Where is UVLrx Therapeutics headquartered?
- UVLrx Therapeutics is headquartered in Santa Barbara, US.